Source:http://linkedlifedata.com/resource/pubmed/id/15929114
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2005-6-6
|
pubmed:abstractText |
Erythrocyte spectrin contains E2/E3 ubiquitin conjugating/ligating activity in its alpha subunit. Ankyrin is a target of spectrin's E2/E3 ubiquitin conjugating/ligating activity in vitro and in vivo. We compare the ubiquitination levels of ankyrin mediated by control and sickle cell spectrin using a biotinylated ubiquitin cell-free assay. Sickle cell spectrin has diminished ability to transfer ubiquitin from an intermediate spectrin-ubiquitin thioester adduct (alpha' spectrin) to ankyrin, which may be due to glutathiolation of spectrin's E2 and/or E3 active site cysteines. There is also a diminished ability of the sickle cell ankyrin to serve as target of spectrin's E2/E3 activity, probably due to oxidative damage to ankyrin. A direct correlation exists between the alpha'/alpha spectrin ratio and spectrin's ability to ubiquitinate ankyrin. There is also an inverse correlation between severity of the disease and the alpha'/alpha spectrin ratio in SS erythrocytes. These results suggest that reduced spectrin E2/E3 activity is an important determinant of sickle cell severity.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Ankyrins,
http://linkedlifedata.com/resource/pubmed/chemical/Ligands,
http://linkedlifedata.com/resource/pubmed/chemical/Protein Isoforms,
http://linkedlifedata.com/resource/pubmed/chemical/Spectrin,
http://linkedlifedata.com/resource/pubmed/chemical/Ubiquitin,
http://linkedlifedata.com/resource/pubmed/chemical/Ubiquitin-Conjugating Enzymes,
http://linkedlifedata.com/resource/pubmed/chemical/Ubiquitin-Protein Ligases
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0361-8609
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
79
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
89-96
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:15929114-Anemia, Sickle Cell,
pubmed-meshheading:15929114-Ankyrins,
pubmed-meshheading:15929114-Blood Cells,
pubmed-meshheading:15929114-Erythrocytes,
pubmed-meshheading:15929114-Humans,
pubmed-meshheading:15929114-Ligands,
pubmed-meshheading:15929114-Protein Isoforms,
pubmed-meshheading:15929114-Severity of Illness Index,
pubmed-meshheading:15929114-Spectrin,
pubmed-meshheading:15929114-Ubiquitin,
pubmed-meshheading:15929114-Ubiquitin-Conjugating Enzymes,
pubmed-meshheading:15929114-Ubiquitin-Protein Ligases
|
pubmed:year |
2005
|
pubmed:articleTitle |
Spectrin's E2/E3 ubiquitin conjugating/ligating activity is diminished in sickle cells.
|
pubmed:affiliation |
Department of Molecular and Cell Biology, UTD Sickle Cell Disease Research Center, Institute of Biomedical Sciences and Technology, The University of Texas at Dallas, Richardson, Texas, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, N.I.H., Extramural
|